A phase II study of small molecule nucleic acid hybrid (SMNH) antiviral compound, SB 9200, in Hepatitis B (HBV) infection.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2015
At a glance
- Drugs SB 9200 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2015 New trial record